Piero Dalerba

About Piero Dalerba

Piero Dalerba, With an exceptional h-index of 36 and a recent h-index of 27 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of Stem Cells, Cancer, Cancer Stem Cells.

His recent articles reflect a diverse array of research interests and contributions to the field:

Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States

Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy

7-UP: Generating in silico CODEX from a small set of immunofluorescence markers

Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy

Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma

Inverse agonists of RAR/RXR signaling as lineage-specific anti-tumor agents against human Adenoid Cystic Carcinoma

Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens

Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

Piero Dalerba Information

University

Position

Assistant Professor

Citations(all)

22190

Citations(since 2020)

6238

Cited By

18649

hIndex(all)

36

hIndex(since 2020)

27

i10Index(all)

43

i10Index(since 2020)

35

Email

University Profile Page

Google Scholar

Piero Dalerba Skills & Research Interests

Stem Cells

Cancer

Cancer Stem Cells

Top articles of Piero Dalerba

Title

Journal

Author(s)

Publication Date

Environmental drivers of the rising incidence of early‐onset colorectal cancer in the United States

International Journal of Cancer

Jianjiu Chen

Mary Beth Terry

Piero Dalerba

Chin Hur

Jianhua Hu

...

2024/2/10

Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy

Cancer Research

Jeremy Worley

Heeju Noh

Daoqi You

Mikko M Turunen

Hongxu Ding

...

2024/2/1

7-UP: Generating in silico CODEX from a small set of immunofluorescence markers

PNAS nexus

Eric Wu

Alexandro E Trevino

Zhenqin Wu

Kyle Swanson

Honesty J Kim

...

2023/6

Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy

bioRxiv

Jeremy Worley

Heeju Noh

Daoqi You

Mikko Turunen

Hongxu Ding

...

2023

Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma

JNCI: Journal of the National Cancer Institute

Sara Viragova

Luis Aparicio

Pierangela Palmerini

Junfei Zhao

Luis E Valencia Salazar

...

2023/7/1

Inverse agonists of RAR/RXR signaling as lineage-specific anti-tumor agents against human Adenoid Cystic Carcinoma

JNCI: Journal of the National Cancer Institute

Sara Viragova

Luis Aparicio

Pierangela Palmerini

Junfei Zhao

Luis E Valencia Salazar

...

2023

Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens

Nature Biomedical Engineering

Zhenqin Wu

Alexandro E Trevino

Eric Wu

Kyle Swanson

Honesty J Kim

...

2022/12

Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

Value in Health

Piero Dalerba

2022/3/1

Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis

Advanced Science

Tianyu Li

Tolulope Akinade

Jie Zhou

Hongxia Wang

Qisong Tong

...

2022/11

A Microsatellite in the Coding Sequence of HLA-A/B Is a Mutation Hotspot in Colon Cancer With Microsatellite Instability

Gastroenterology

William J Raab

Arabella Mazzocchi

Paolo Radice

Debashis Sahoo

Chiara Castelli

...

2022/3/1

Elucidation and pharmacological targeting of master regulator proteins representing mechanistic determinants of breast cancer stem-like tumor initiating cell state

Cancer Research

Jeremy Worley

Hongxu Ding

Heeju Noh

Evan Paull

Aaron T Griffin

...

2022/6/15

Treatment of cancer with dual targeting of cd47 and egfr

2022/2/3

Method of treating adenoid cystic carcinoma

2022/2/3

Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells

Journal of gastroenterology

Shigeo Hisamori

Junko Mukohyama

Sanjay Koul

Takanori Hayashi

Michael Evan Rothenberg

...

2022/6

Phenotypic dissection of epithelial lineages and therapeutic manipulation of differentiation programs in human Adenoid Cystic Carcinomas (ACCs)

bioRxiv

Sara Viragova

Luis Aparicio

Junfei Zhao

Luis E Valencia Salazar

Alexandra Schurer

...

2022/1/21

SPACE-GM: geometric deep learning of disease-associated microenvironments from multiplex spatial protein profiles

bioRxiv

Zhenqin Wu

Alexandro E Trevino

Eric Wu

Kyle Swanson

Honesty J Kim

...

2022/5/13

Methods for treating, preventing and detecting the prognosis of colorectal cancer

2021/9/23

Abstract PR07: A systems biology approach to reprogramming drug-resistant breast cancer stem-like cells

Cancer Research

Jeremy Worley

Hongxu Ding

Heeju Noh

Evan Paull

Erin Bush

...

2020/11/1

Notch signaling mediates differentiation in Barrett’s esophagus and promotes progression to adenocarcinoma

Gastroenterology

Bettina Kunze

Frederik Wein

Hsin-Yu Fang

Akanksha Anand

Theresa Baumeister

...

2020/8/1

A trial of Lopinavir–Ritonavir in Covid-19

N Engl J Med

Piero Dalerba

Bruce Levin

John L Thompson

2020/3/20

See List of Professors in Piero Dalerba University(Columbia University in the City of New York)

Co-Authors

academic-engine